Dissertation > Excellent graduate degree dissertation topics show

The Curative Effect and Analysis of Thromboprophylaxis with Low-molecular-weight Heparin

Author: GaoLiLi
Tutor: WuTaiHua
School: Dalian Medical University
Course: Internal Medicine
Keywords: low-molecular-weight heparin deep vein thrombosis the anti-FXa activity
CLC: R687.4
Type: Master's thesis
Year: 2008
Downloads: 62
Quote: 0
Read: Download Dissertation

Abstract


Background and Objective:In recent years,low-molecular-weight heparin(LMWH) has been widely used in the direction of the prophylaxis and treatment of venous thromboembolism.For its many merits ,LMWH has taken the place of unfractionated heparin (UFH ) as the main anticoagulant.Now there is an agreement of using the plasma anti-FXa activity to evaluate the value of LMWH.The anti-Xa levels at 4h after subcutaneous administration of a dose (peak levels) which varied between 0.5-1.0U/ml are most suitable for therapy.But in practice,doctors also find deep vein thrombosis(DVT) even pulmonary thromboembolism(PTE) happened in patients who are accepting the prophylaxis treatment of LMWH,which may do harm to the lives of patients.So in order to guide the application of LMWH in thromboprophylaxis,we design this experiment.Methods:we chose 20 patients who were treated with unilateral total hip replacement in the department of orthopaedics of the first affiliated hospital of DaLian Medical University from October to December in 2007 by a series of severe standards.Eight were male and twelve were female.They aged between 25-88 years,average 61.7 years and weighted between 54-88kg,average 65.8kg.These patients were injected subcutaneouly with LMWH 2500U differently at preoperative 12h,postoperative 12h and at 9 o’clock daily from the first day after operation.The anti-FXa activity in plasma was monitered when they were hospitalized and at 4h after injection LMWH on day 1 and 3.To observe (1)Is there any difference in the plasma anti-FXa activity after thromboprophylaxis with LMWH 2500U.(2)Does the plasma anti-FX activity at 4h after injection achieve to optimal levels 0.5-1.0U/ml.(3)The relationship between the anti-FXa activity and weight.Results:(1)There was significant increasement in the anti-FXa activity of thromboprophylaxis with LMWH 2500U,but the plasma anti-FXa activity after injection at 4h on day 1 and 3 didn’t achieve to the optimal levels 0.5-1.0U/ml.(2)There was no relationship between the anti-FXa activity and weight by drawing scatterplot.Conclusions:(1)The maximal plasma anti-FXa activity of thromboprophylaxis with LMWH 2500U didn’t achieve to the optimal levels 0.5-1.0U/ml.We suggested to increase the dose ,such as administration of LMWH 5000U once daily.(2)There was no relationship between the anti-FXa activity and weight.For general patients,we can use a fixed amount of heparin.

Related Dissertations

  1. Study on the Preparation of the Low Molecular Weight Fuciodan from Sargassum Henslowianum (C.Agardh) and Anti-tumor Activity,TS254.9
  2. The Application Research of Heparin and Protamine Ratio for the Hepatitis B (or Carriers) Patients Undergoing Valve Replacement Operation,R512.62
  3. Experimental Study of Proliferation of EPCs Effected by 3-MA in Rat’s Chronic Deep Vein Thrombosis,R543.6
  4. The Improvement of Post-treatment Technology of Heparin Production Process and the Study of Low Molecular Weight Heparin Production Process,R94
  5. Fine Structure Analysis of Low Molecular Weight Heparin,R927
  6. Dacron grafts and properties of surface modification of materials,R318.08
  7. Study on the New Method for the Determination of Polysaccharides by Resonance Rayleigh Scattering Techniques,O657.3
  8. Study on Syntheses and Anticoagulant Mechanism of Anticoagulant Action Complexes,R914
  9. Subacute Deep Venous Thrombosis after CRT Device Implantation,R541.6
  10. The Influence of Xuebijing Injection and Low Molecular Weight Heparin on Coagulation Function and Prognosis in the Patients with Severe Sepsis,R459.7
  11. The Changes and Significance of vWF、AT in Low-molecular-weight-heparin Used in Severe Pre-eclampsia Patients,R714.2
  12. The Effect of Ulinastatin Continuous Infusion on Coagulation System in Major Orthopedic Surgery,R614
  13. Clinical Analysis of Off-pump Coronary Artery Bypass Grafting,R654.2
  14. Effectiveness and Safety of Catheter-directed Thrombolysis Versus Anticoagulation for Iliofemoral Venous Thrombosis: a Systematic Review and Meta-analyses of Randomized Controlled Trials.,R654.4
  15. Effects to Crops and Soil Under Polyethylene As the Main Ingredient of Degradable Plastic Film,X173
  16. Relationship between Lowerextremity Deep Venous Thrombosis and Highsensitive C-reactive Protein, D-dimer and Homocysteine,R543.6
  17. Comparison on the Effects of Domestic Bivalirudin and Heparin on Coagulation, Fibrinolytic System and Platelets Activity in Rats,R96
  18. Safety and Effectiveness of Dalteparin Versus Unfractionated Heparin During Elective Percutaneous Coronary Interventions,R541.4
  19. Low molecular weight heparin on chronic obstructive pulmonary disease rat model of intercellular adhesion molecule-1 , monocyte chemoattractant protein-1 expression,R563.9
  20. Low molecular weight heparin-induced thrombocytopenia morbidity and related factors,R595.3
  21. The Histology-based Preliminary Study on Animal Species Selection, Preparation and Implantation of Xenogenic Acellular Dermal Matrix,R644

CLC: > Medicine, health > Surgery > Orthopaedic Surgery ( movement system diseases,orthopedic surgery ) > Orthopedic surgery and surgery > Joint Surgery
© 2012 www.DissertationTopic.Net  Mobile